Neural-interface technology for therapeutic signals
| Date | Round | Amount |
|---|---|---|
| Jan 2022 | Seed CereGate took an investment from 468 Capital for its neural-interface technology. | — |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.